Pediatric Hypopituitarism Clinical Presentation

  • Author: Joel W Steelman, MD; Chief Editor: Stephen Kemp, MD, PhD   more...
 
Updated: Jul 14, 2011
 

History

The clinical presentation of hypopituitarism, which widely varies, depends on the patient's age, the etiology, and the specific hormone deficiencies, which may occur as isolated deficiencies or in various combinations of MPHD. Presenting signs and symptoms may develop insidiously and can be nonspecific, requiring a high index of suspicion.

Neonates

Most neonates with hypopituitarism have normal or even high birth weights and lengths and no history of intrauterine growth retardation. However, they often have histories of breech presentation (particularly neonates with MPHD), although the explanation for this is unclear. Microgenitalia, mainly in males, may result from a gonadotropin deficiency or from GH deficiency.

The hypoglycemia risk is higher in neonates with hypopituitarism, with various manifesting symptoms, such as lethargy, jitteriness, pallor, cyanosis, apnea, or convulsions. Jaundice may be secondary to indirect hyperbilirubinemia (as occurs in TSH axis deficiency) or to direct hyperbilirubinemia (as occurs in GH or ACTH axis deficiencies).

Neonates with hypopituitarism may have undergone several evaluations to exclude sepsis or for unexplained apnea, hypotension, or temperature instability. Consider hypopituitarism as a possible diagnosis when these conditions occur in a full-term infant.

Electrolyte disturbances can also occur in neonates with hypopituitarism. Hyponatremia unassociated with hypovolemia and unresponsive to fluid restriction can develop. In contrast to the hyponatremia that occurs with the salt-losing crisis of 21-hydroxylase deficiency, serum potassium levels are typically low or within the reference range. The hyponatremia resolves with physiologic corticosteroid replacement.[18] Hypernatremia secondary to excess free-water loss associated with uncontrolled diabetes insipidus may also occur.

Depending on the etiology of the hypopituitarism, associated findings in the neonate, infant, or child may include developmental delay, various visual and neurologic symptoms, seizure disorder, and a number of congenital malformation syndromes.

Older infants and children

Common presenting features include growth failure, disorders of pubertal development, and diabetes insipidus. Growth failure may be the most common presenting symptom in this age group, possibly with an associated delay in tooth development. Hypoglycemia, although less frequent, can also be a presenting sign of hypopituitarism in older infants and children. Patients with acquired or milder forms of gonadotropin deficiency who do not present with microgenitalia in infancy may present later with absent or delayed puberty.

Central diabetes insipidus secondary to ADH deficiency can be difficult to recognize in infancy, because patients often present with nonspecific signs (eg, irritability, unexplained fever). Symptoms of polyuria and polydipsia are more readily obvious in older children.

Patients with hypothyroidism secondary to a TSH axis deficiency present with signs and symptoms identical to those of primary hypothyroidism, although typically less severe. These include fatigue, cold intolerance, constipation, dry skin, slow growth, and weight gain.

Depending on the etiology of the hypopituitarism, associated findings in the neonate, infant, or child may include developmental delay, various visual and neurologic symptoms, seizure disorder, and a number of congenital malformation syndromes. Optic nerve hypoplasia has been associated with a spectrum of endocrine abnormalities, from isolated GHD to MPHD. Patients with acquired hypopituitarism, caused by a suprasellar tumor, often present with headaches, visual disturbances, and other neurologic symptoms.

Anencephaly is associated with variable pituitary hypoplasia and complete absence of the hypothalamus. Various forms of holoprosencephaly particular associated with HESX1 mutations may be associated with hypopituitarism.

Next

Physical Examination

Neonates

Birth weights and lengths are typically within the reference range in neonates with hypopituitarism. Important physical signs in the neonate that may suggest a diagnosis of hypopituitarism include microgenitalia, jaundice, and physical evidence of possible hypoglycemia (ie, jitteriness, pallor).[19]

Microgenitalia includes micropenis (which has a well-documented association with hypopituitarism) and an underdeveloped clitoris. Micropenis is defined as stretched penile length less than 2.5 cm (reference range mean length is 4 cm). Data on normal clitoral size, including that for different gestational ages, are also available.[20] Cryptorchidism is often associated with micropenis.

Optic nerve hypoplasia is associated with hypopituitarism; the presence of small, pale optic disks or nystagmus should prompt consideration of hypopituitarism.[21, 22]

Older infants and children

Growth failure (see the image below) is the most important sign to recognize in hypopituitarism. Growth failure may often exist for a considerable period of time before it is recognized. In addition to short stature and abnormal growth rate, the affected child may show evidence of delayed skeletal maturation (eg, delayed dental development).

The left photograph shows an untreated 21-month-olThe left photograph shows an untreated 21-month-old girl with congenital hypopituitarism. The right panel depicts the same child aged 29 months, following 8 months of growth hormone therapy.

During the physical examination, pay particular attention to pubertal development, because patients with hypopituitarism may present with microgenitalia in infancy or with delayed or absent puberty. Anosmia, particularly in a patient with delayed or absent puberty, should prompt consideration of Kallmann syndrome (KS).

Weight gain typically is out of proportion to growth, resulting in relative obesity. This obesity is truncal in distribution; skull and head circumference growth are typically preserved, producing the impression of a large head. Craniofacial features of pituitary GHD include craniofacial disproportion (ie, normal head circumference, small facies, prominent forehead, frontal bossing). The presence of a central incisor is an important, finding because it may represent hypopituitarism in a midline CNS abnormality.

Visual and neurologic abnormalities may represent important features associated with hypopituitarism. When not recognized in infancy, optic nerve hypoplasia may be noted in childhood as decreased visual acuity. Signs that may indicate the potential presence of a suprasellar mass include decreased visual acuity, visual field defects, papilledema, and/or optic atrophy.

Previous
 
 
Contributor Information and Disclosures
Author

Joel W Steelman, MD  Endocrine Consultant, Division of Endocrinology and Diabetes, Cook Children's Medical Center

Joel W Steelman, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Clinical Endocrinologists, American Society for Bone and Mineral Research, Endocrine Society, and Pediatric Endocrine Society

Disclosure: Pfizer Honoraria Speaking and teaching

Specialty Editor Board

Phyllis W Speiser, MD  Chief, Division of Pediatric Endocrinology, Steven and Alexandra Cohen Children's Medical Center of New York; Professor of Pediatrics, Hofstra-North Shore LIJ School of Medicine at Hofstra University

Phyllis W Speiser, MD is a member of the following medical societies: American Association of Clinical Endocrinologists, Endocrine Society, Pediatric Endocrine Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

George P Chrousos, MD, FAAP, MACP, MACE, FRCP(London)  Professor and Chair, First Department of Pediatrics, Athens University Medical School, Aghia Sophia Children's Hospital, Greece; UNESCO Chair on Adolescent Health Care, University of Athens, Greece

George P Chrousos, MD, FAAP, MACP, MACE, FRCP(London) is a member of the following medical societies: American Academy of Pediatrics, American College of Endocrinology, American College of Physicians, American Pediatric Society, American Society for Clinical Investigation, Association of American Physicians, Endocrine Society, Pediatric Endocrine Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Chief Editor

Stephen Kemp, MD, PhD  Professor, Department of Pediatrics, Section of Pediatric Endocrinology, University of Arkansas for Medical Sciences College of Medicine, Arkansas Children's Hospital

Stephen Kemp, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, American Association of Clinical Endocrinologists, American Pediatric Society, Endocrine Society, Phi Beta Kappa, Southern Medical Association, and Southern Society for Pediatric Research

Disclosure: Nothing to disclose.

Acknowledgments

I want to thank Simon Rhodes, PhD and Stephen Shalet, MD for kindly allowing me to republish illustrations from their work.

References
  1. Mehta A, Hindmarsh PC, Mehta H, Turton JP, Russell-Eggitt I, Taylor D, et al. Congenital hypopituitarism: clinical, molecular and neuroradiological correlates. Clin Endocrinol (Oxf). Mar 6 2009;[Medline].

  2. Parks JS, Kinoshita EI, Pfaffle RW. Pit-1 and hypopituitarism. Trends Endocrinol Metab. 1993;4:81-5.

  3. Rosenbloom AL, Almonte AS, Brown MR, et al. Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab. Jan 1999;84(1):50-7. [Medline]. [Full Text].

  4. Lebl J, Vosahlo J, Pfaeffle RW, et al. Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects. Eur J Endocrinol. Sep 2005;153(3):389-96. [Medline].

  5. Bottner A, Keller E, Kratzsch J, et al. PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J Clin Endocrinol Metab. Oct 2004;89(10):5256-65. [Medline]. [Full Text].

  6. Fluck C, Deladoey J, Rutishauser K, et al. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg-->Cys at codon 120 (R120C). J Clin Endocrinol Metab. Oct 1998;83(10):3727-34. [Medline]. [Full Text].

  7. Mullen, R.D., Colvin, S.C., Hunter, C.H., et al. Roles of the LHX3 and LHX4 LIM-homeodomain factors in pituitary development. Mol. Cell. Endocrinol. 2007;265:190-195.

  8. Kim SS, Kim Y, Shin YL, et al. Clinical characteristics and molecular analysis of PIT1, PROP1, LHX3, and HESX1 in combined pituitary hormone deficiency patients with abnormal pituitary MR imaging. Horm Res. 2003;60(6):277-83. [Medline].

  9. Pinto G, Netchine I, Sobrier ML, et al. Pituitary stalk interruption syndrome: a clinical-biological-genetic assessment of its pathogenesis. J Clin Endocrinol Metab. Oct 1997;82(10):3450-4. [Medline]. [Full Text].

  10. Darzy KH, Shalet SM. Hypopituitarism following Radiotherapy. In: Wallace WHB, Kelnar CJH. Endocrinopathy after Childhood Cancer Treatment. 15. Basel: Karger; 2009:1-24.

  11. Ghigo E, Masel B, Aimaretti G, et al. Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Inj. Aug 20 2005;19(9):711-24. [Medline].

  12. Acerini CL, Tasker RC. Endocrine Sequelae of Traumatic Brain Injury in Childhood. Horm Res. 2007;68(suppl 5):14-17.

  13. Sklar CA. Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg. 1994;21 Suppl 1:18-20. [Medline].

  14. Mootha SL, Barkovich AJ, Grumbach MM, et al. Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents. J Clin Endocrinol Metab. May 1997;82(5):1362-7. [Medline]. [Full Text].

  15. Lindsay R, Feldkamp M, Harris D, et al. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr. Jul 1994;125(1):29-35. [Medline].

  16. Regal M, Parmo C, Sierra SM, Garcia-Mayor RV. Prevaence and Incidence of Hypopituitarism in an Adult Caucasian Population in Northwestern Spain. Clin Endocrinol. 2001;55:735-740.

  17. Stochholm K, Laursen T, Green A, Laurberg P, Andersen M, Kristensen LØ, et al. Morbidity and GH deficiency: a nationwide study. Eur J Endocrinol. Apr 2008;158(4):447-57. [Medline].

  18. White SM, Campbell DJ. Primary hypopituitarism and peri-operative steroid supplementation. Anaesthesia. Mar 2009;64(3):336-7. [Medline].

  19. Choo-Kang LR, Sun CC, Counts DR. Cholestasis and hypoglycemia: manifestations of congenital anterior hypopituitarism. J Clin Endocrinol Metab. Aug 1996;81(8):2786-9. [Medline].

  20. Sane K, Pescovitz OH. The clitoral index: a determination of clitoral size in normal girls and in girls with abnormal sexual development. J Pediatr. Feb 1992;120(2 Pt 1):264-6. [Medline].

  21. Garcia-Filion P, Epport K, Nelson M, Azen C, et al. Neuroradiographic, Endocrinologic, and Ophthalmic Correlates of Adverse Developmental Outcomes in Children With Optic Nerve Hypoplasia: A Prospective Study. Pediatrics. 2008;121:e653-e659.

  22. Borchert M, Garcia-Filion P. The Syndrome of Optic Nerve Hypoplasia. Current Neurology and Neuroscience Reports. 2008;8:395 - 403.

  23. Argyropoulou MI, Kiortsis DN. MRI of the hypothalamic-pituitary axis in children. Pediatr Radiol. Nov 2005;35(11):1045-55. [Medline].

  24. Rosenfeld RG. Disorders of growth hormone and insulin-like growth factor secretion and action. Pediatric Endocrinology. 1996;117-169.

  25. Weinzimer SA, Homan SA, Ferry RJ, Moshang T. Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours. Clin Endocrinol. 1999;51(3):339-45.

  26. Jostel A, Ryder WD, Shalet SM. The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index. Clin Endocrinol (Oxf). Feb 18 2009;[Medline].

  27. Toogood AA, Stewart PM. Hypopituitarism: Clinical Featues, Diagnosis, and Management. In: Barkan AL. Endocrinology and Metabolism Clinics of North America. 37. 1. Philadelphia: Elsevier Saunders; 2008:235-261.

Previous
Next
 
The left photograph shows an untreated 21-month-old girl with congenital hypopituitarism. The right panel depicts the same child aged 29 months, following 8 months of growth hormone therapy.
Regulation of the development of the mammalian anterior pituitary gland by transcription factors. Following, inductive signals between the developing diencephalon and the oral ectoderm, early transcription factors guide the formation of rudimentary Rathke's Pouch (rRP) and then subsequent gene regulatory pathways control the determination, proliferation, and differentiation events that establish the specialized hormone-secreting cells. AP = anterior pituitary, IP = intermediate pituitary, PP = posterior pituitary. Modified by S. Rhodes from Mullen, R.D., Colvin, S.C., Hunter, C.H., Savage, J.J., Walvoord, E.C., Bhangoo, A.P.S., Ten, T., Weigel, J., Pfäffle, R.W., and Rhodes, S.J. (2007). Roles of the LHX3 and LHX4 LIM-homeodomain factors in pituitary development. Mol. Cell. Endocrinol., 265-266: 190-195.
Summary of Neuroendocrine Dysfunction following radiotherapy (courtesy of Stephen M Shalet, MD)
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.